Guaifenesin and Dextromethorphan Hydrobromide
- Product NDC
- 24689-123
- 11-digit product format
- 246890123
- Labeler code
- 24689
- Product ID
- 24689-123_f17dcc88-303d-4e1f-e053-2a95a90ae08d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin and Dextromethorphan Hydrobromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- APNAR PHARMA LP
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-12-30
- Marketing end
- 0000-00-00
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
- Active strength
- 20 mg/1; mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 24689-123 | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE TABLET [APNAR PHARMA LP] | 3 | Legacy NDC | 20230108_e22b0c01-390f-2743-e053-2995a90aee29.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 24689-123-01 | 24689012301 | 20 TABLET in 1 BOTTLE (24689-123-01) | 20 tablet | 2022-06-30 | 0000-00-00 | No | No | Current |
| 24689-123-02 | 24689012302 | 500 TABLET in 1 BOTTLE (24689-123-02) | 500 tablet | 2022-06-30 | 0000-00-00 | No | No | Current |